Should access to GLP-1 weight-loss drugs be publicly reimbursed?
14 votes|10 arguments|0 source
Obesity drives diabetes, heart disease and cancer costs. Reimbursing effective treatments saves money long-term and improves lives. @@yes_1
Quasi-experimental study exploiting staggered platform rollouts across US universities.
Comparative overview of how surrogacy is regulated across 46 European jurisdictions, from outright bans to fully commercial frameworks.
Estimation annuelle de la mortalité attribuable aux particules fines (PM2.5) à l'échelle des aires urbaines.
Meta-analysis of 28 studies on physical and psychological outcomes for gestational surrogates and the children they carry.